88IV - PR Newswire Asia's news - Health Care/Hospital

< Previous page

| Title only | Print

Next page >

Ping An Unveils Innovative AI Solutions in Healthcare, Insurance and Payments at WAIC 2026 HONG KONG and SHANGHAI , July 21, 2026 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. ("Ping An", the "Company" or the "Group"; HKEX: 2318; SSE: 601318) unveiled ... 2026-07-21T Banking/Financial Service Computer Software Computer/Electronics Health Care/Hospital
Rege Nephro Secures approximately US$10.6 Million to Advance RN-014 Toward Commercialization Financing will support development of RN-014 and RN-032 and continued expansion of the company's kidney disease pipeline ... 2026-07-21T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
ESMO 2026 \| Mabwell to Present Latest Clinical Data on Nectin-4-targeting ADC 9MW2821 for Triple Negative Breast Cancer in Oral Presentation SHANGHAI , July 21, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, will present the latest clinical study results ... 2026-07-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
SuanNutra, Parent Company of Monteloeder and a Carbyne Equity Partners Portfolio Company, Expands Product Portfolio with Specialty Natural Ingredients Businesses from IFF MADRID , July 21, 2026 /PRNewswire/ -- SuanNutra, the global science-backed ingredients group, today announced it has signed an agreement to acquire a portfolio of specialty natural ingredients businesses ... 2026-07-21T Chemical Food/Beverages Health Care/Hospital Medical/Pharmaceuticals
Telix Q2 Revenue US$247M, Strong Momentum and Pipeline Progress MELBOURNE, Australia and INDIANAPOLIS , July 21, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") provides a market update on its commercial and operational ... 2026-07-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Telix Doses First Patient in Phase 3 LUTEON Trial of TLX250-Tx for Renal Cancer • First patient dosed in Phase 3 LUTEON [1] trial evaluating TLX250-Tx in relapsed or recurrent clear cell renal cell carcinoma (ccRCC). • LUTEON is the first Phase 3 study of a CAIX [2] -targeted ... 2026-07-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
PharmaBlock Convenes Global Industry Leaders in Zurich to Advance Green Chemistry for Sustainable Pharmaceutical Manufacturing ZURICH , July 20, 2026 /PRNewswire/ -- As Europe experienced one of its hottest Junes on record, with prolonged heatwaves reinforcing the urgency of climate action, leaders from the pharmaceutical industry ... 2026-07-20T Chemical Environmental Products & Services Health Care/Hospital Medical/Pharmaceuticals
Lundbeck announces last patient randomized in DEEp OCEAN, a large Phase III trial in developmental and epileptic encephalopathies (DEEs) DEEp OCEAN is a global trial designed to evaluate the investigational molecule bexicaserin for the treatment of seizures associated with DEEs, a diverse group of childhood-onset epilepsies 1 Broadest ... 2026-07-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Medtrum Advances 300U Tubeless Patch Pump Toward German Launch Higher-capacity option expands the TouchCare Nano System and supports Medtrum's continued growth in Europe ... 2026-07-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Antengene Announces Poster Presentation of ATG-022 and ATG-037 at ESMO 2026 SHANGHAI and HONG KONG , July 20, 2026 /PRNewswire/ -- Antengene Corporation Limited ( "Antengene" , SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated ... 2026-07-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved